Pilates breathing versus pursed‑lip breathing for adults with mild COPD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study enrolls 46 adults with mild COPD who are divided into two groups: one group practices Pilates breathing plus standard pharmacological management and the other practices pursed‑lip breathing plus standard pharmacological management. Outcomes measured include chest expansion, peak expiratory flow rate, dyspnea, and quality of life before and after the intervention. Eligible participants are aged 40–64, have GOLD mild COPD (FEV1 ≥80% predicted) with mMRC grade 1–3 dyspnea, and can follow instructions. The trial is conducted at the Foundation University College of Physical Therapy in Islamabad and focuses on simple, non‑invasive breathing techniques added to usual care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age between 40-64 years
* Both genders (male and female)
* Grade 1-3 on mMRC scale of dyspnea
* COPD mild stage according to global initiative for chronic obstructive lung disease (GOLD) classification; Mild = FEV1 greater than or equal to 80% predicted

Exclusion Criteria:

* Moderate, severe and very severe stage of COPD according to GOLD classification
* Patients having acute exerbation of COPD
* Patients diagnosed with acute infection
* Patients unable to follow command and instructions

Where it's running

• Foundation University College of Physical Therapy, Islamabad, 44000
  Rawalpindi, Pakistan Recruiting

Study contacts

• Study coordinator: Sana Kalim, DPT
• Email: sanakalim408@gmail.com
• Phone: 03369169645

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Coherent Breathing vs Regular Paced Breathing for COPD Dyspnea and Lung Function

  In this study, adults with COPD test whether coherent breathing helps reduce shortness of breath and improve breathing tests compared with regular paced breathing.

  Recruiting Foundation University Islamabad · Rawalpindi · NCT07875036

• Real-time monitoring and early warning for COPD patients on home NIV

  This observational study tests a multisensor real-time monitoring system to see if it can predict acute COPD flare-ups in adults using home noninvasive ventilation.

  Recruiting Beijing Chao Yang Hospital · Beijing · NCT07701096

• Box breathing added to short pulmonary rehabilitation for COPD breathlessness and exercise capacity

  This test will see whether adding box breathing to a short pulmonary rehabilitation program helps people aged 40–65 with mild COPD breathe easier and improve their functional capacity.

  Recruiting Foundation University Islamabad · Islamabad · NCT07518472

• 611 for moderate-to-severe COPD in Chinese adults

  This will test whether 611 reduces flare-ups and is safe for Chinese adults aged 40–85 with moderate to severe COPD who have had recent exacerbations.

  Recruiting at 2 sites Phase 3 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Beijing, Beijing Municipality and 3 other locations · NCT07039669

• Chronic Respiratory Disease Participant Engagement

  This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.

  Recruiting Richmond Pharmacology Limited · London · NCT07924462

• IOS-based platform to screen, diagnose, and manage COPD and asthma

  This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.

  Recruiting Beijing Chao Yang Hospital · Beijing, Beijing Municipality · NCT07910409

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.